Savasi Valeria, Oneta Monica, Laoreti Arianna, Parisi Francesca, Parrilla Bina, Duca Piergiorgio, Cetin Irene
1 Unit of Obstetrics and Gynecology, Department of Biomedical and Clinical Sciences, ASST Fatebenefratelli Sacco, Hospital "L. Sacco," University of Milan, Italy.
2 Centre for Fetal Research Giorgio Pardi, University of Milan, Italy.
Am J Mens Health. 2018 Nov;12(6):1835-1842. doi: 10.1177/1557988318794282. Epub 2018 Aug 22.
HIV-1-affected couples' desire to have children and free sexual intercourses with the use of pre-exposure prophylaxis for the negative partner has emerged as an alternative option to assisted reproduction in aviremic patients under highly active antiretroviral therapy (HAART). It is already known that sperm quality may be impaired in HIV-infected men. The underlying physiopathological mechanism is still debated. The aim of this study was to evaluate the effects of HAART on sperm DNA fragmentation, comparing HIV-1-infected patients taking HAART versus naïve HIV-1-infected patients. This is a prospective case-control study. Sperm nuclear DNA fragmentation rate was evaluated by the sperm chromatin dispersion test in 77 HIV-infected men: 53 HIV-1 patients receiving HAART (Group 1) versus 24 naïve HIV-1 patients not receiving HAART (Group 2). Complete semen analysis was performed according to WHO 2010 recommendations. Patients with HBV infection or HCV infection coinfections and genital tract infections wre excluded. All the patients did not present any clinical signs of their disease. Seminal parameters were examined in the two groups, showing no significant differences. Increased sperm DNA fragmentation > 30% was demonstrated in 67.9% of patients in Group 1 and 37.5% of patients in Group 2, respectively ( p = .02). A positive but nonsignificant trend toward increased fragmentation was reported with advancing patients' age. In conclusion, sperm nuclear fragmentation rate is increased in HIV-1-infected patients taking HAART compared to HIV-1 patients not receiving HAART.
在高效抗逆转录病毒疗法(HAART)下,受HIV-1感染的夫妇想要孩子并让未感染的一方通过暴露前预防措施进行无保护性交,已成为病毒血症患者辅助生殖的一种替代选择。已知HIV感染男性的精子质量可能受损。其潜在的生理病理机制仍存在争议。本研究的目的是评估HAART对精子DNA片段化的影响,比较接受HAART的HIV-1感染患者与未接受治疗的初治HIV-1感染患者。这是一项前瞻性病例对照研究。通过精子染色质扩散试验评估了77名HIV感染男性的精子核DNA片段化率:53名接受HAART的HIV-1患者(第1组)和24名未接受HAART的初治HIV-1患者(第2组)。根据世界卫生组织2010年的建议进行了完整的精液分析。排除了合并HBV感染或HCV感染以及生殖道感染的患者。所有患者均无疾病的任何临床症状。对两组的精液参数进行了检查,结果显示无显著差异。第1组67.9%的患者和第2组37.5%的患者精子DNA片段化增加> 30%(p = 0.02)。随着患者年龄的增加,报告了片段化增加的正向但不显著趋势。总之,与未接受HAART的HIV-1患者相比,接受HAART的HIV-1感染患者的精子核片段化率增加。